Reverse transcriptase-IN-1, CAS [[2380001-43-2]]

Produktübersicht

• Artikelname: Reverse transcriptase-IN-1, CAS [[2380001-43-2]]
• Artikelnummer: MCE-HY-130241
• Hersteller Artikelnummer: HY-130241
• Alternativnummer: MCE-HY-130241-100MG,MCE-HY-130241-5MG,MCE-HY-130241-50MG,MCE-HY-130241-10MG,MCE-HY-130241-10MMX1ML,MCE-HY-130241-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Reverse transcriptase-IN-1 (Compound 12z), a diarylbenzopyrimidine (DABP) analogue, is a potent, orally active HIV-1 nonnucleoside reverse transcriptase inhibitor. Reverse transcriptase-IN-1 has antiviral activity with EC50 values of 3.4 nM, 4.3 nM and 3.6 nM for HIV-1 IIIB, E138K and K103N mutants, respectively. Reverse transcriptase-IN-1 also has an IC50of 13.7 nM against HIV-1 reverse transcriptase enzyme[1].

Produkteigenschaften

• Molekulargewicht: 447.45
• Reinheit: 98.08
• CAS Nummer: [2380001-43-2]
• Formel: C25H17N7O2
• Target-Kategorie: HIV

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound